Skip to main content
AVTX filings

Corporate insider profile

Mittie Doyle Filing Activity

Latest reported as Chief Medical Officer of Avalo Therapeutics, Inc. (AVTX).

Purchase filings
0
Reported companies
1
Net open-market value
-$2,881,877.79
Latest transaction
Aug 17, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 17, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale1,000$20.00$20,000
Aug 10, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale679$20.00$13,580
Jul 27, 2026Avalo Therapeutics, Inc. (AVTX)Chief Medical OfficerSale1,000$20.00$20,000